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Abstract Given its rarity, appropriate treatment for pin-
eocytoma remains variable. As the literature primarily
contains case reports or studies involving a small series of
patients, prognostic factors following treatment of pineo-
cytoma remain unclear. We therefore compiled a system-
atic review of the literature concerning post-treatment
outcomes for pineocytoma to better determine factors
associated with overall survival among patients with pin-
eocytoma. We performed a comprehensive search of the
published English language literature to identify studies
containing outcome data for patients undergoing treatment
for pineocytoma. Kaplan–Meier analysis was utilized to
determine overall survival rates. Our systematic review
identiﬁed 168 total patients reported in 64 articles. Among
these patients, 21% underwent biopsy, 38% underwent
subtotal resection, 42% underwent gross total resection,
and 29% underwent radiation therapy, either as mono- or
adjuvant therapy. The 1 and 5 year overall survival rates
for patients receiving gross total resection versus subtotal
resection plus radiotherapy were 91 versus 88%, and 84
versus 17%, respectively. When compared to subtotal
resection alone, subtotal resection plus radiation therapy
did not offer a signiﬁcant improvement in overall survival.
Gross total resection is the most appropriate treatment
for pineocytoma. The potential beneﬁt of conventional
radiotherapy for the treatment of these lesions is unproven,
and little evidence supports its use at present.
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Introduction
Pineocytomas account for 0.4–1.0% of all intracranial
tumors [1]. The published literature on the appropriate
management of this tumor is sparse due to the relative
rarity of this lesion, and thus management of pineocytoma
varies between centers based on clinician preference.
Studies often combine pineocytomas with other pineal
region tumors of different histologies [2, 3]. This is a
signiﬁcant limitation of such analyses, as different tumor
histology portends markedly different prognoses, and
requires different treatment paradigms.
Because of these limitations, the expected prognosis for
patients with these tumors after surgery is not well known
[3, 4]. Further, the relative beneﬁt of post-operative adju-
vant radiotherapy for patients with this tumor is not known,
and thus the importance of obtaining gross total resection is
unclear. Due to the difﬁcult location of these tumors and
the high risk of serious neurological complications, this is
an important question that demands a more deﬁnitive
answer [5].
To attempt to address these concerns, we systematically
reviewed the published literature with the aim of deter-
mining if surgical resection of any kind is superior to
biopsy alone, if subtotal resection with adjuvant post-
operative radiotherapy can replace gross total resection, as
it has in other tumors, and to determine the role of radio-
therapy in patients with subtotal resection.
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Article selection
A systematic search of the existing English language lit-
erature was conducted to assemble a comprehensive review
of overall survival after treatment of pineocytoma. Articles
were identiﬁed via PubMed search using Boolean searches
with key words ‘‘pineocytoma’’ alone and in combination
with ‘‘treatment,’’ ‘‘mortality,’’ and ‘‘morbidity.’’ After
reviewing these articles, a thorough review of all references
was additionally performed.
All references that contained disaggregated data spe-
ciﬁcally addressing post-treatment survival with adequate
follow-up in patients who had undergone surgery (biopsy
or resection) of histologically conﬁrmed pineocytoma were
included in our analysis. Any paper that did not provide at
least some follow-up survival data for pineocytoma
patients was excluded.
Data extraction
Tumor characteristics including median largest dimension
and volume were not consistently reported in our included
studies, preventing analysis. Treatment modality was strat-
iﬁed into three groups based on reported extent of resection.
These included gross total resection (GTR), subtotal resec-
tion (STR), and simply biopsy. Further substratiﬁcation of
datawasperformedbasedontreatmentwithorwithoutpost-
operative adjuvant fractionated radiotherapy (XRT).
Useable data regarding stereotactic radiosurgery as sole
or post-operative adjuvant therapy for this lesion was too
sparse (2 patients) to draw any meaningful statistical
comparisons, and thus these patients were excluded from
our analysis. Overall survival (PFS) was calculated at the
1-year and 5-year time points. If study data were presented
such that these variables could not be reliably ascertained,
these studies were excluded from further analysis.
Statistical analysis
Pearson’s v
2 test was used to analyze for differences in pre-
operative categorical factors including gender and presence
of hydrocephalus. Fisher’s exact test was used if there were
less than ﬁve values per cell. Analysis of variance
(ANOVA) was used to evaluate for statistical differences in
pre-operative continuous factors, including age. Kaplan–
Meier analysis was used to generate overall survival
curves. Differences in time to mortality were analyzed by
the log-rank test. Cox proportional hazard modeling was
used to assess for differences in overall survival adjusting
for differences in pre-operative variables. Analyses were
carried out using SPSS version 16.0 (SPPS, Inc.).
Results
Clinical characteristics of included patients
Our search identiﬁed a total of 64 references [1–64] which
met our inclusion criteria, providing disaggregated data on
168 patients with pineocytoma (Table 1). Males made up
52% of the population, and females 48%. The median age
among patients was 30 years. Presenting symptoms most
commonly encountered included headaches (75%), nausea
(23%), and visual changes (17%). The presenting sign most
commonly encountered included hydrocephalus (65%).
Most tumors were of conventional histology (72%).
146 patients included data describing extent of tumor
resection. Of these, 61 (42%) underwent GTR, 55 (38%)
underwent STR, and 30 patients (21%) underwent biopsy.
Post-operative XRT or radiosurgery (RS) was utilized on
29% of patients. Patients were followed from 3 to
165 months. Shorter follow-up times were reported in case
reports or among patients who expired.
The effect of surgical resection of any kind compared
to biopsy alone
When comparing rates of overall survival in patients who
underwent biopsy, with or without radiation therapy, and
those who underwent any surgical resection, with or without
radiation therapy, there were no signiﬁcant differences
between the two groups in gender or age (v
2 P = 0.8,
ANOVA P = 0.06, respectively). Notably, patients treated
withsurgicalresectionsufferedpre-operativehydrocephalus
Table 1 Clinical characteristics
Number of patients (%)
Gender
M/F 86/80 (52)
Median age (range) 30 (2–74)
Hydrocephalus
Present at diagnosis 97/149 (65)
Absent at diagnosis 52/149 (35)
Histology
Conventional 121/168 (72)
Neuronal 24/168 (14)
Other 23/168 (14)
Treatment
Biopsy 30/146 (21)
STR 55/146 (38)
GTR 61/146 (42)
Post-operative adjuvant radiation
Yes 66/168 (39)
No 102/168 (61)
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123more often than patients undergoing biopsy alone (71 vs.
50%, v
2 P\0.05). When comparing surgical resection
versusbiopsy,the1and5 yearoverallsurvivalrateswere89
versus 82%, and 76 versus 64%, respectively. Although the
trend was toward improved survival with surgical resection,
this difference did not reach statistical signiﬁcance (log-
rank, P = 0.19) (Fig. 1). Thus, despite a suggestion of
beneﬁt we have insufﬁcient data to deﬁnitive conclude that
surgical resection provides a survival beneﬁt compared to a
biopsy with or without XRT.
Subtotal resection with adjuvant radiation cannot
replace gross total resection
Overall survival rates between patients undergoing GTR
without radiation therapy versus patients undergoing sub-
total resection STR plus adjuvant XRT were compared to
analyze potential prognostic factors. When comparing
patient characteristics between the two groups, there were
no signiﬁcant differences in gender (v
2 P = 0.4), age
(ANOVA P = 0.9), or presence of hydrocephalus (Fisher’s
exact test P = 0.08). The one and ﬁve- year overall sur-
vival rates for the GTR group versus the STR plus XRT
group was 91% versus 88%, and 84 versus 17%, respec-
tively. On Kaplan–Meier analysis, these differences rep-
resented a statistically signiﬁcant improvement (log-rank,
P\0.05) (Fig. 2).
The role of adjuvant radiation in cases of subtotal
resection
We performed a subgroup analysis to determine whether
post-operative adjuvant XRT combined with STR offered a
survival advantage compared to patients receiving STR
alone. There were no signiﬁcant differences in gender
(Fisher’s exact P = 0.2), age (ANOVA P = 0.8), or pre-
operative rates of hydrocephalus between the groups
(Fisher’s exact P = 0.6). The 1 and 5 year overall survival
rates for the STR group versus the STR plus XRT group
was 77 versus 88%, and 77 versus 17%, respectively.
Although there is a trend toward decreased survival in
patients treated with subtotal resection plus radiation
therapy, this difference was not statistically signiﬁcant
(log-rank, P = 0.14) (Fig. 3).
Discussion
At present, the post-treatment prognosis of patients with
pineocytoma remains unclear. Furthermore, there is no
Fig. 1 Comparison of overall survival between patients treated with
surgical resection (solid line) versus biopsy and radiation (dashed
line)
Fig. 2 Comparison of overall survival between patients treated with
gross total resection (solid line) compared to subtotal resection and
postoperative radiotherapy (dashed line)
Fig. 3 Comparison of overall survival between patients treated with
subtotal resection alone (solid line), compared to subtotal resection
and postoperative radiotherapy (dashed line)
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123clear agreement on what treatment course to utilize in order
to best minimize patient mortality rates [65, 66]. The rarity
of these tumors has made it difﬁcult to deﬁne the behavior
of this lesion and its response to therapy.
In lieu of class 1 data, we have systematically reviewed
the published English language literature on pineocytoma
in an attempt to provide better information and guidance in
the management of these tumors. Our analysis suggests that
aggressive surgical resection provides a survival beneﬁt
over subtotal resection. When compared to GTR, the
addition of adjuvant XRT to STR does not appear to pro-
vide an equivalent survival outcome.
On further analysis of patients receiving STR versus
those undergoing STR plus XRT, the addition of adjuvant
radiation does not yield a survival beneﬁt when compared
to STR alone. Considered in light of the superiority of GTR
to STR, it would appear that pineocytoma is relatively
resistant to radiation and is optimally treated with aggres-
sive surgery rather than XRT.
Study limitations
Our goal in authoring the current study was to summarize
the published literature regarding pineocytoma. However,
it should be acknowledged that this review is not class 1 or
2 data, and should ideally be supplanted with more deﬁn-
itive data if and when this becomes available. Our analysis
is limited by the quality and accuracy composite studies,
and may reﬂect source study biases. It is impossible for us
to control for the quality of the data reported in the liter-
ature. We cannot conﬁrm the histologic grade, extent of
resection, and adequacy of radiation therapy, which likely
vary between studies, therefore rendering it impossible to
validate these common deﬁnitions across all publications in
which they are reported. Furthermore, our use of Kaplan–
Meier analysis largely precludes the use of formal meta-
analysis methods, including the calculation of a Q-statistic
which allows for a determination of survival data hetero-
geneity. This consequently prevents us from addressing the
potential for systematic ﬂaws or differences among studies
in a statistically meaningful way. Finally, due to the diverse
range of data presentation, we are limited in our ability to
study and control for certain variables. Potential con-
founders inconsistently presented across studies cannot be
reviewed.
Conclusion
In conclusion, we have assembled a systematic review of
the published pineocytoma literature and offer data on
survival rates following different treatment strategies.
These data appear to indicate optimal survival rates
following GTR. Given the relatively rarity of this tumor,
this study aims to improve upon the small sample sizes
offered by individual institutions by providing a more
comprehensive review of outcome characteristics for
patients with pineocytoma.
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